Stelara (Janssen Biotech, Inc.)
Welcome to the PulseAid listing for the Stelara drug offered from Janssen Biotech, Inc.. This Interleukin-12 Antagonist [EPC],Interleukin-12 Antagonists [MoA],Interleukin-23 Antagonist [EPC],Interleukin-23 Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Janssen Biotech, Inc. |
| NON-PROPRIETARY NAME: | ustekinumab |
| SUBSTANCE NAME: | USTEKINUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Interleukin-12 Antagonist [EPC],Interleukin-12 Antagonists [MoA],Interleukin-23 Antagonist [EPC],Interleukin-23 Antagonists [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2016-09-23 |
| END MARKETING DATE: | 0000-00-00 |
Stelara HUMAN PRESCRIPTION DRUG Details:
| Item Description | Stelara from Janssen Biotech, Inc. |
| LABELER NAME: | Janssen Biotech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 130(mg/26mL) |
| START MARKETING DATE: | 2016-09-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57894-054_9864a6b0-c4cd-4c9e-b39b-737172835dd1 |
| PRODUCT NDC: | 57894-054 |
| APPLICATION NUMBER: | BLA761044 |
Other USTEKINUMAB Pharmaceutical Manufacturers / Labelers:
